KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AbCellera Biologics (ABCL) Other Non Operating Income (2020 - 2026)

AbCellera Biologics filings provide 7 years of Other Non Operating Income readings, the most recent being $4.3 million for Q1 2026.

  • Quarterly Other Non Operating Income rose 4.48% to $4.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$2.5 million through Mar 2026, down 102.74% year-over-year, with the annual reading at -$2.7 million for FY2025, 104.35% down from the prior year.
  • Other Non Operating Income hit $4.3 million in Q1 2026 for AbCellera Biologics, up from -$13.3 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $52.2 million in Q4 2024 and bottomed at -$13.3 million in Q4 2025.
  • Average Other Non Operating Income over 5 years is $6.4 million, with a median of $3.5 million recorded in 2024.
  • The largest annual shift saw Other Non Operating Income plummeted 558.28% in 2022 before it soared 1446.27% in 2024.
  • AbCellera Biologics' Other Non Operating Income stood at -$3.8 million in 2022, then surged by 189.34% to $3.4 million in 2023, then soared by 1446.27% to $52.2 million in 2024, then tumbled by 125.45% to -$13.3 million in 2025, then surged by 132.66% to $4.3 million in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Other Non Operating Income are $4.3 million (Q1 2026), -$13.3 million (Q4 2025), and $2.7 million (Q3 2025).